KIMBERLY TULLOCH: Open Payments
NPI 1427327394 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 34 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $202 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 13 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $208 |
| Otsuka America Pharmaceutical, Inc. | 4 | $130 |
| ABBVIE INC. | 4 | $85 |
| Lilly USA, LLC | 3 | $56 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Leqembi, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, REXULTI, KISUNLA, INGREZZA, COBENFY.
Industry payments across NJ — which companies pay providers there.
